The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience

EuroIntervention 2012;7:1170-1180. DOI: 10.4244/EIJV7I10A188

1. Manchester Heart Centre, Manchester Royal Infirmary, Biomedical Research Centre, Manchester, United Kingdom; 2. Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; 3. Interventional Cardio

Aims: The Sideguard® stent (Cappella Medical Devices Ltd, Galway, Ireland), is a novel nitinol self-expanding dedicated bifurcation stent th

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry